[Expression and Role of Peroxisome Proliferator-Activated Receptor Gamma and Nuclear Factor-Kappab in Pulmonary Fibrosis].

Qing Lin,Lian Fang Ni,Ya Li Ren,Xin Min Liu
DOI: https://doi.org/10.3969/j.issn.1671-167x.2009.05.008
2009-01-01
Abstract:OBJECTIVE:To evaluate the expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and nuclear factor-kappaB (NF-kappaB) in lungs in patients with pulmonary fibrosis, and to explore their effect on the pathogenesis of pulmonary fibrosis.METHODS:Immunohistochemical technology was performed to investigate the PPARgamma and NF-kappaB expression in lung specimens from 16 cases of pulmonary fibrosis and 10 cases of normal controls.RESULTS:The positive score of PPARgamma (0.35+/- 0.08) in fibrosis group was lower than that in control group (0.42+/-0.04, P<0.05). The positive score of NF-kappaB (0.51+/- 0.11) in fibrosis group was higher than that in control group (0.38+/-0.04, P<0.05). There was negative correlation between PPARgamma and NF-kappaB expression in fibrosis group (P<0.05).CONCLUSION:The decreased expression of PPARgamma and enhanced expression of NF-kappaB play a role in the pathogenesis of pulmonary fibrosis, which may provide a new idea for treating this disease.
What problem does this paper attempt to address?